Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer
Stephanie Dorta-Estremera, Venkatesh L. Hegde, Ravaen B. Slay, Rachel Sun, Ananta V. Yanamandra, Courtney Nicholas, Sita Nookala, Gloria Sierra, Michael A. Curran, K. Jagannadha Sastry
Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 252; DOI: 10.1186/s40425-019-0728-4
